Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Thalassemia D013789 8 associated lipids
Carbon Monoxide Poisoning D002249 9 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Leukopenia D007970 9 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Salmonella Infections, Animal D012481 9 associated lipids
Immune Complex Diseases D007105 9 associated lipids
Gastroesophageal Reflux D005764 10 associated lipids
Rhinitis D012220 10 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Pancreatitis D010195 10 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Shock D012769 11 associated lipids
Infertility, Male D007248 11 associated lipids
Migraine Disorders D008881 11 associated lipids
Meningioma D008579 11 associated lipids
Pregnancy Complications, Hematologic D011250 11 associated lipids
Pregnancy Complications, Cardiovascular D011249 11 associated lipids
Shock, Septic D012772 11 associated lipids
Venous Thrombosis D020246 11 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Fetal Weight D020567 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Death, Sudden D003645 12 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Amnesia D000647 12 associated lipids
Hypertension, Portal D006975 12 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Heart Arrest D006323 13 associated lipids
Polycythemia Vera D011087 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Angina, Unstable D000789 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Stomatitis D013280 14 associated lipids
Neutropenia D009503 15 associated lipids
Encephalitis D004660 15 associated lipids
Thrombocytopenia D013921 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Hemorrhage D006470 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Johnson M et al. Levocetirizine and rupatadine in chronic idiopathic urticaria. 2015 Int. J. Dermatol. pmid:25521304
Kim H et al. Higher plasma platelet-activating factor levels are associated with increased risk of vertebral fracture and lower bone mineral density in postmenopausal women. 2015 J. Bone Miner. Metab. pmid:25501698
Mullol J et al. Update on rupatadine in the management of allergic disorders. 2015 Allergy pmid:25491409
Zhao YM and Maimone TJ Short, enantioselective total synthesis of chatancin. 2015 Angew. Chem. Int. Ed. Engl. pmid:25470723
Kattan JD and Sicherer SH Optimizing the diagnosis of food allergy. 2015 Immunol Allergy Clin North Am pmid:25459577
Vlachogianni IC et al. Platelet Activating Factor (PAF) biosynthesis is inhibited by phenolic compounds in U-937 cells under inflammatory conditions. 2015 Prostaglandins Other Lipid Mediat. pmid:26358846
Sato A et al. Angiotensin peptides attenuate platelet-activating factor-induced inflammatory activity in rats. 2015 Peptides pmid:26348270
Damiani E et al. Platelet-Activating Factor Induces Epigenetic Modifications in Human Mast Cells. 2015 J. Invest. Dermatol. pmid:26316070
Starossom SC et al. Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation. 2015 Circ. Res. pmid:26294656
Kulinski JM et al. Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function. 2016 Eur. J. Pharmacol. pmid:25941085
Wang M et al. The Responses of Pulmonary and Systemic Circulation and Airway to Allergic Mediators in Anesthetized Rats. 2016 Biol. Pharm. Bull. pmid:27040628
Carretta MD et al. Butyric acid stimulates bovine neutrophil functions and potentiates the effect of platelet activating factor. 2016 Vet. Immunol. Immunopathol. pmid:27288853
Liu R et al. Pyruvate in oral rehydration salt improves hemodynamics, vasopermeability and survival after burns in dogs. 2016 Burns pmid:27130433
Grambow E et al. Differential effects of endogenous, phyto and synthetic cannabinoids on thrombogenesis and platelet activity. 2016 Biofactors pmid:27151562
Eleftheriou K et al. Comparative Experimental and Computational Study of Monoalkyl Chain Phosphatidylcholine-Containing Thermoresponsive Liposomes. 2016 J Phys Chem B pmid:27280363
Megson IL et al. Lipids and cardiovascular disease: where does dietary intervention sit alongside statin therapy? 2016 Food Funct pmid:27109548
Farbman KS and Michelson KA Anaphylaxis in children. 2016 Curr. Opin. Pediatr. pmid:26963947
Sahu RP et al. Radiation therapy generates platelet-activating factor agonists. 2016 Oncotarget pmid:26959112
Müllers SM et al. Altered Platelet Function in Intrauterine Growth Restriction: A Cause or a Consequence of Uteroplacental Disease? 2016 Am J Perinatol pmid:26906182
Nimjee SM et al. Translation and Clinical Development of Antithrombotic Aptamers. 2016 Nucleic Acid Ther pmid:26882082
Moschos MM et al. Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study. 2016 Drug Des Devel Ther pmid:27994439
Vadas P The platelet-activating factor pathway in food allergy and anaphylaxis. 2016 Ann. Allergy Asthma Immunol. pmid:27788869
Pike DP et al. Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode. 2016 Lipids pmid:27757707
Täubel J et al. Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial. 2016 PLoS ONE pmid:27632557
Hoenderdos K et al. Hypoxia upregulates neutrophil degranulation and potential for tissue injury. 2016 Thorax pmid:27581620
Watanabe M et al. Characterization of platelet-activating factor-induced cutaneous edema and erythema in dogs. 2016 Am. J. Vet. Res. pmid:27580108
González-Núñez V et al. Rupatadine: global safety evaluation in allergic rhinitis and urticaria. 2016 Expert Opin Drug Saf pmid:27500993
Kamaladasa A et al. Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators. 2016 Antiviral Res. pmid:27476044
Schauberger E et al. Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets. 2016 Curr Allergy Asthma Rep pmid:27333777
Wang JM and Chen J Damage of vascular endothelial barrier induced by explosive blast and its clinical significance. 2016 Chin. J. Traumatol. pmid:27321288
Nel JG et al. Pneumolysin Mediates Platelet Activation In Vitro. 2016 Lung pmid:27192991
Silva-Herdade AS et al. Erythrocyte deformability - A partner of the inflammatory response. 2016 Microvasc. Res. pmid:27142964
Wang M et al. The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice. 2016 Life Sci. pmid:26808090
Quinn RA et al. Metabolomics of reef benthic interactions reveals a bioactive lipid involved in coral defence. 2016 Proc. Biol. Sci. pmid:27122568
Lecewicz M et al. Effects of the platelet-activating factor (PAF) on selected quality parameters of cryopreserved bull semen (AI) with reduced sperm motility. 2016 Pol J Vet Sci pmid:27096799
Damiani E and Ullrich SE Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer. 2016 Prog. Lipid Res. pmid:27073146
Jacob SP et al. Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-Tolerance. 2016 PLoS ONE pmid:27064683
Eser A et al. Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients. 2016 Taiwan J Obstet Gynecol pmid:26927250
Guequén A et al. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability. 2016 Am. J. Physiol. Heart Circ. Physiol. pmid:26921435
Bihl JC et al. UVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor Signaling. 2016 Photochem. Photobiol. pmid:26876152
Reiner B et al. Platelet-activating factor attenuation of long-term potentiation in rat hippocampal slices via protein tyrosine kinase signaling. 2016 Neurosci. Lett. pmid:26808643
Unsal E et al. Effects of pentoxifylline and platelet activating factor on sperm DNA damage. 2016 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:26748389
Park JH et al. Glucosamine suppresses platelet-activating factor-induced activation of microglia through inhibition of store-operated calcium influx. 2016 Environ. Toxicol. Pharmacol. pmid:26745504
Rodríguez M et al. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells. 2016 Biochem. Pharmacol. pmid:26673542
Aquino EN et al. Proteomic Analysis of Neutrophil Priming by PAF. 2016 Protein Pept. Lett. pmid:26631175
Anandi VL et al. Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures. 2016 Oncol. Rep. pmid:26531049
Wright NR et al. Purulent Pericarditis and Abscessed Myocardium with Acute Myocardial Infarction. 2016 Am. J. Med. pmid:26524710
Kim HK et al. Glutamine Prevents Late-Phase Anaphylaxis via MAPK Phosphatase 1-Dependent Cytosolic Phospholipase A2 Deactivation. 2016 Int. Arch. Allergy Immunol. pmid:27838690
Wang Y et al. Attenuated Reactive Gliosis and Enhanced Functional Recovery Following Spinal Cord Injury in Null Mutant Mice of Platelet-Activating Factor Receptor. 2016 Mol. Neurobiol. pmid:26084439
Kelly AM et al. The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial. 2017 Blood pmid:28487294